Literature DB >> 2630927

[Vertebral hemangioma with neurologic signs. Therapeutic results. Survey of the French Society of Neurosurgery].

J P Nguyen1, M Djindjian, J M Pavlovitch, S Badiane.   

Abstract

45 cases of vertebral hemangiomas with neurologic involvement are reported. This series corresponds to the french experience between 1969 to 1988 (series of the "Société Française de Neuro-Chirurgie" (S.F.N.)). In this report, the therapeutic results are detailed. 16 patients were treated by a simple laminectomy, 6 by laminectomy associated with radiotherapy, 4 by radiotherapy alone. In 9 patients, a large removal of the hemangioma was performed by mean of a lamino-arthrectomy (7 cases) or a corporectomy (2 cases). 7 patients were treated by embolization or vertebroplasty. Both techniques were used alone or in association with surgery or radiotherapy. 3 patients had no therapy. Results of the S.F.N. series demonstrated that 75.5% of the patients had a long term favorable clinical course. 13.4% of the patients were not improved. Mortality was of 11.1%. The mean follow up time was of 51.6 months. Recurrence was encountered in 13 cases. It was mainly observed in the first two years. In cases of total involvement of the vertebrae by hemangioma, laminectomy associated with radiotherapy was the best mean of therapy: 93% of recovery without recurrence. Treatment of body localization appeared to be difficult. Corporectomy could be unefficient if a complete removal of the hemangioma could not be performed. In contrast, posterior arch localization was successfully treated by a simple laminectomy without radiotherapy, even in cases of incomplete removal of the hemangioma: all such cases (10 cases) had a complete recovery without recurrence.

Entities:  

Mesh:

Year:  1989        PMID: 2630927

Source DB:  PubMed          Journal:  Neurochirurgie        ISSN: 0028-3770            Impact factor:   1.553


  7 in total

1.  Surgery in extensive vertebral hemangioma: case report, literature review and a new algorithm proposal.

Authors:  Roberto Tarantino; Pasquale Donnarumma; Lorenzo Nigro; Roberto Delfini
Journal:  Neurosurg Rev       Date:  2015-02-27       Impact factor: 3.042

2.  Position statement on percutaneous vertebral augmentation: a consensus statement developed by the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, American Association of Neurological Surgeons/Congress of Neurological Surgeons, and American Society of Spine Radiology.

Authors:  M E Jensen; J K McGraw; J F Cardella; J A Hirsch
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

3.  Vertebral haemangiomas with spinal cord compression: the place of preoperative percutaneous vertebroplasty with methyl methacrylate.

Authors:  C Ide; A Gangi; A Rimmelin; R Beaujeux; D Maitrot; F Buchheit; F Sellal; J L Dietemann
Journal:  Neuroradiology       Date:  1996-08       Impact factor: 2.804

4.  DEGRO guidelines for the radiotherapy of non-malignant disorders : part III: hyperproliferative disorders.

Authors:  M Heinrich Seegenschmiedt; Oliver Micke; Marcus Niewald; Ralph Mücke; Hans Theodor Eich; Jan Kriz; Reinhard Heyd
Journal:  Strahlenther Onkol       Date:  2015-03-10       Impact factor: 3.621

5.  [The significance of radiation therapy for symptomatic vertebral hemangiomas (SVH)].

Authors:  Reinhard Heyd; M Heinrich Seegenschmiedt; Dirk Rades; Cornelia Winkler; Hans T Eich; Frank Bruns; Georg Gosheger; Normann Willich; Oliver Micke
Journal:  Strahlenther Onkol       Date:  2010-07-29       Impact factor: 3.621

Review 6.  [Percutaneous vertebroplasty (pv): indications, contraindications, and technique].

Authors:  R T Hoffmann; T F Jakobs; A Wallnöfer; M F Reiser; T K Helmberger
Journal:  Radiologe       Date:  2003-09       Impact factor: 0.635

7.  Hémangiome vertébral neuro-agressif de révélation tardive: cas cliniqueA clinical case of late-onset aggressive vertebral hemangioma with neurological signs.

Authors:  Komi Ignéza Agbotsou; Damelan Kombate; Amégninou Mawuko Yao Adigo; Kossivi Apétsè; Albert Beschet; Victor Chan
Journal:  Pan Afr Med J       Date:  2020-11-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.